NCT03397862View on ClinicalTrials.gov

A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System

PHASE1CompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

November 14, 2017

Primary Completion Date

March 8, 2018

Study Completion Date

April 2, 2018

Conditions
Skin IrritationSensitization
Interventions
DRUG

Donepezil TDS

Donepezil patch

DRUG

Vehicle TDS

Placebo patch

Trial Locations (2)

68502

Celerion Inc., Lincoln

85283

Celerion Inc., Phoenix

All Listed Sponsors
lead

Corium, Inc.

INDUSTRY

NCT03397862 - A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System | Biotech Hunter | Biotech Hunter